Project Grant R01NS138507

Award Date 4/1/25
Completion Date 3/31/30
Dollars Obligated $525K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This federal Project Grant award of $676,812 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA Program 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders supports research to investigate the mechanisms by which the KCTD family of proteins regulate G protein-coupled receptors (GPCRs) in the nervous system. The primary awardee, Weill Medical College of Cornell University, will conduct structural studies of GABAB receptor-KCTD...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), will support research to investigate the structural and functional characteristics of kainate receptors (KARs). KARs play a critical role in excitatory neurotransmission in the central nervous system, and genetic variations in KAR subunits have been associated with neurological and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $877,447 to develop therapeutic approaches for a genetic disorder caused by gain-of-function mutations in the KCNQ3 gene. The goal is to inhibit KCNQ3 expression in the central nervous system using an adeno-associated viral vector-based gene therapy approach. In the initial R61 phase, the...
This $121,554 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support research into understanding the role of the KIF5A gene in amyotrophic lateral sclerosis (ALS). The research aims to investigate how ALS-related mutations in KIF5A impact RNA processing and contribute to motor neuron degeneration. Key objectives include...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $195,000 to investigate the cellular mechanisms by which Long QT Syndrome (LQTS) type 2-associated KCNH2 gene variants disrupt neuronal function. The research will utilize gene-edited and patient-derived human stem cell-derived neurons to determine how LQTS2-linked KCNH2...
This $564,186 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) seeks to investigate how a specific genetic mutation (PACS2E209K) associated with a neurodevelopmental disorder known as PACS2 syndrome impacts neuronal metabolism and neurotransmission. The research, to be conducted at the University of Pittsburgh, will utilize advanced live-cell...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support a study to identify novel genetic causes of infantile epilepsies and evaluate the impact of genetic diagnosis on patient outcomes. The $230,904 award to The Children's Hospital Corporation in Boston will fund cutting-edge genomic analyses to pinpoint pathogenic germline and mosaic...
The National Institute of General Medical Sciences (NIGMS) awarded a $501,985.34 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Arkansas, Fayetteville Division. The grant, which runs from Aug 12, 2024 to Jul 31, 2027, will support research to investigate the structural consequences of protein kinase C (PKC)-dependent phosphorylation of the Kv7.2 protein, which is critical for regulating neuron excitability and linked to epilepsy....
This $225,180 five-year Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders supports research by an Assistant Professor of Pediatrics at Northwestern University investigating the role of mitochondrial metabolism in inhibitory GABAergic interneurons. The proposed research aims to: 1) Use an in vitro iPSC-derived inhibitory interneuron system to evaluate acute...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), provides $145,642 to support research on the role of voltage-gated sodium channels (VGSCs) in neurodevelopmental epilepsy. The project aims to use human induced pluripotent stem cell-derived brain organoids to study the non-canonical functions of VGSCs, such as their influence on cellular...

This federal Project Grant award of $525,436 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to elucidate the molecular mechanisms underlying the loss of potassium selectivity and constitutive activation observed in Keppen-Lubinsky Syndrome (KLS) disease mutations in the GIRK2 potassium channel. The research team at the Icahn School of Medicine at Mount Sinai will use a multi-disciplinary approach combining structural biology, computational modeling, and human neuron cell models to identify and characterize novel selective inhibitors of the KLS GIRK2 channels. This work aims to develop a foundation for a potential new treatment for the severe neurological symptoms associated with KLS, a rare genetic disorder characterized by developmental delays, intellectual disability, and neuromuscular abnormalities.

Generated 4/8/25, 4:31 AM